← All trials
NCT07138560
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 24, 2025
- Primary completion
- May 15, 2026
- Completion date
- May 15, 2027
- First posted
- Aug 24, 2025
- Last posted
- Aug 24, 2025
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Cleveland ClinicLead sponsor
- The Cleveland ClinicSponsor investigator
- Amneal PharmaceuticalsCollaborator
- The Cleveland ClinicOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.